Spinocerebellar ataxia type 3: from pathogenesis to promising therapeutics
- PMID: 40707300
- DOI: 10.1016/j.molmed.2025.06.007
Spinocerebellar ataxia type 3: from pathogenesis to promising therapeutics
Keywords: Machado-Joseph disease; gene silencing; polyglutamine disorders; spinocerebellar ataxia type 3; therapeutics.
Conflict of interest statement
Declaration of interests The authors declare no competing interests.
LinkOut - more resources
Full Text Sources
